Week In Review: LianBio To Close Operations; Will Pay $528 Million To Shareholders
February 17, 2024 at 14:20 PM EST
LianBio, a Princeton-Shanghai biotech, has decided to call it quits. LianBio plans to stop all of its operations by the end of 2024, and it will distribute a $4.80 dividend/share ($528 million) to its shareholders.
